DOI: 10.1055/s-00000036

Laryngo-Rhino-Otologie

References

Brahmer JR, Drake CG, Wollner I. et al.
Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.

J Clin Oncol 2010;
28: 3167-3175

Download Bibliographical Data

Search in:
Access: